公开(公告)号：US07671039B2

公开(公告)日：2010-03-02

申请号：US10578133

申请日：2004-10-28

Applicant: Hyun-Dong Shin ,  Mi-Kyung Son ,  Bok-Ryun Park ,  Chang-Woo Son ,  Hee-Jeong Jang

Inventor： Hyun-Dong Shin ,  Mi-Kyung Son ,  Bok-Ryun Park ,  Chang-Woo Son ,  Hee-Jeong Jang

IPC: A61K31/716

CPC classification number: A61K36/07 ,  A61K31/716

Abstract: The present invention relates to a composition containing beta-glucan as an effective ingredient for prevention and treatment of osteoporosis. The above captioned beta-glucan is preferably the beta-1.3/1.6 glucan having a lactic acid as a substituent and this beta-1.3/1.6 glucan is preferably produced from Aureobasidium pullulans SM2001(KCCM 10307).

Abstract translation: 本发明涉及含有β-葡聚糖作为预防和治疗骨质疏松症的有效成分的组合物。 上述标题的β-葡聚糖优选是具有乳酸作为取代基的β-1.3 / 1.6葡聚糖，并且该β-1.3 / 1.6葡聚糖优选地由助枝菌属（Sureia）属的松属杆菌SM2001（KCCM 10307）产生。

公开(公告)号：US20070117777A1

公开(公告)日：2007-05-24

申请号：US10578133

申请日：2004-10-28

Applicant: Hyun-Dong Shin ,  Mi-Kyung Son ,  Bok-Ryun Park ,  Chang-Woo Son ,  Hee-Jeong Jang

Inventor： Hyun-Dong Shin ,  Mi-Kyung Son ,  Bok-Ryun Park ,  Chang-Woo Son ,  Hee-Jeong Jang

IPC: A61K31/716

CPC classification number: A61K36/07 ,  A61K31/716

Abstract: The present invention relates to a composition containing beta-glucan as an effective ingredient for prevention and treatment of osteoporosis. The above captioned beta-glucan is preferably the beta-1.3/1.6 glucan having a lactic acid as a substituent and this beta-1.3/1.6 glucan is preferably produced from Auerobasidium pullulans SM2001(KCCM 10307).

Abstract translation: 本发明涉及含有β-葡聚糖作为预防和治疗骨质疏松症的有效成分的组合物。 上述标题的β-葡聚糖优选是具有乳酸作为取代基的β-1.3 / 1.6葡聚糖，该β-1.3 / 1.6葡聚糖优选由支链淀粉杆菌SM2001（KCCM 10307）产生。